DH participates in 2026 emergency drill for medical products safety incident in Hong Kong and Macao organised by Guangdong Provincial Medical Products Administration to deepen regulatory collaboration in Greater Bay Area (with photos)
******************************************************************************************
Guangdong, Hong Kong and Macao have maintained close communication and collaboration in medical products safety regulation, continuously deepening their collaboration through the annual GBA Medical Products Administration Conference. To further enhance emergency response capabilities and regional collaboration for medical products safety within the GBA, and to comprehensively safeguard the safe use and required quality of medical products, the governments of Guangdong, Hong Kong, and Macao have signed the Memorandum of Understanding on Drugs and Medical Devices Monitoring and Co-operation in the GBA. In addition, the GDMPA and the Health Commission of Guangdong Province jointly issued the Contingency Plan of Guangdong Province for Safety Incidents of Imported Drugs and Medical Devices from Hong Kong and Macao to Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area (Trial) (the Contingency Plan). To effectively implement the Contingency Plan, the GDMPA organised today's large‑scale drill to further refine collaboration capabilities.
The drill featured a cross‑boundary regulatory investigation scenario, simulating a medical product safety incident involving the Hong Kong SAR and the Macao SAR. The simulation depicted an adverse event occurring at a designated healthcare institution using Hong Kong-registered drugs and medical devices used in Hong Kong public hospitals in the GBA, while using urgently needed medical products from Hong Kong and Macao, triggering a level II drug safety incident response in Guangdong Province. The drill tested practical operational procedures on mechanisms for incident monitoring and reporting, emergency response activation, on‑site handling, public‑opinion management and interdepartmental co-ordination. Through real-time information sharing via the cross-boundary risk alert notification mechanism among Guangdong, Hong Kong and Macao, the drill reviewed the emergency response capabilities of cross-boundary collaboration in the GBA.
More than 300 participants took part in the drill, providing valuable reference points and strong support for continuously improving the contingency collaboration mechanism among the three regions. It will not only help to enhance Hong Kong's ability to respond to medical products safety emergencies, but also further promote co-operation and experience sharing among the regulatory authorities in Guangdong, Hong Kong and Macao.
The DH will continue to strengthen close communication and deep co-operation with relevant departments within the GBA, and jointly enhance regional medical products safety regulation and emergency collaboration mechanisms to protect public health. In addition, the Hong Kong Centre for Medical Products Regulation (CMPR) under the DH will be established by this year. It will shoulder the important responsibilities of promoting highly efficient and rigorous "primary evaluation", strengthening the approval mechanism for medical products to ensure their safety and efficacy, while maintaining the highest standards of supply chain integrity through stringent surveillance and enforcement measures to prevent substandard products from entering the market, ensuring that all medical products used by patients meet the requirements of quality, safety and efficacy. The CMPR will offer a world-class regulatory environment to support the approval for innovative medical products and expedite their clinical applications, thereby driving the development of industries relating to research and development as well as testing of medical products. It will help ensure that the approval mechanism of Hong Kong is recognised both internationally and by the Chinese Mainland to elevate the city's status as an international health and medical innovation hub.
Ends/Wednesday, September 23, 2026
Issued at HKT 15:00
Issued at HKT 15:00
NNNN
Photo
